logologo
QuantliQuantli

Surrozen Inc

SRZN

NASDAQ

Biotechnology

$23.96

USD

+0.23 (+0.97%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $278.91M

Volume 212.9K

Price (USD)
Price (USD)

About Surrozen Inc

The company is headquartered in South San Francisco, California and currently employs 44 full-time employees. The company went IPO on 2020-11-23.

CEO

Mr. Craig Parker

HQ

South San Francisco, CALIFORNIA, US

Founded

2020

Employees

44

Quantli Score

8.4

Outperform

Fin. Health

8.1

Profitability

7.6

Growth

9.0

Cash-Flow Q.

8.8

Key Metrics

5 metrics our research team weighs before forming a view on SRZN.

Based on Quantli research · SEC filings · as of Q2 2026

METRIC

VALUE

CHANGE

TREND (3Y)

Revenue Growth (TTM)

-8.8%

Gross Margin (TTM)

100.0%

0.0 pp

Operating Margin (TTM)

-385.3%

-179.8 pp

Net Margin (TTM)

-2885.3%

-2753.0 pp

Free Cash Flow (TTM)

$-34.98M

Financial Snapshot

Full Financials

Revenue

$11.51M

-8.8%

YoY

Gross Margin

100%

TTM

0.0%

YoY

Net Income

$-332.13M

-1889.2%

YoY

Operating Cash Flow

$-34.76M

-86.3%

YoY

Key Statistics

Open

$23.84

Previous Close

$23.73

Day Range

$22.84 - $24.95

52 Week Range

$10.11 - $35.00

Volume

212.9K

Average Volume (10 Days)

330.0K

Dividend Yield

Valuation Measurement

Market Cap

$278.91M

P/E Ratio (TTM)

P/S Ratio (TTM)

24.23

Financial Highlights

Profit Margin

-2885.3%

Return on Assets

-287.3%

Return on Equity

151.9%

Revenue (TTM)

$11.51M

Net Income (TTM)

$-332.13M

Diluted EPS (TTM)

-$40.39

Total Cash (MRQ)

$102.04M

Levered FCF (TTM)

$-34.98M

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Go deeper on SRZN

Similar Stocks

SION

Sionna Therapeutics Inc

$6.46

-1.2%

AVXL

Anavex Life Sciences Corp

$3.22

-1.5%

ANIK

Anika Therapeutics Inc

$21.50

+1.6%

MYGN

Myriad Genetics Inc

$3.03

-4.4%

RNAC

Cartesian Therapeutics Inc

$8.84

+1.4%

TRDA

Entrada Therapeutics Inc

$7.46

+0.1%

ALXO

ALX Oncology Holdings Inc

$1.96

+1.0%

ZSQR

Z Squared Inc (Delaware)

$3.94

-5.3%

ELDN

Eledon Pharmaceuticals Inc

$3.54

-4.3%

Analyst Consensus

Buy

Based on 1 analyst ratings

Avg Target: $44.00

(+83.6% upside)

High: $44.00 · Low: $44.00

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

View full analyst ratings